News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website


Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This is so sad. I had high hopes for this trial. The earlier phase 2 trial reported very good results.  The details have not been released yet - would love to see how the 2 trials differed and why the phase 3 trial did not show a benefit when the phase 2 showed such a large benefit. 


Posted on: 03/08/2018

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740